|
Market Closed -
London S.E.
11:35:17 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 1,675.00 GBX | +2.13% |
|
+4.69% | -12.07% |
| 03-30 | BioVentix confident on future despite profit decline in first half | AN |
| 03-30 | WINNERS & LOSERS: boohoo to beat view; Abingdon Health wins deals | AN |
Company Valuation: Bioventix PLC
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 206.8 | 179.7 | 201 | 229.7 | 143.7 | 87.52 |
| Change | - | -13.1% | 11.82% | 14.29% | -37.44% | -39.09% |
| Enterprise Value (EV) 1 | 206.8 | 173.6 | 201 | 223.7 | 138.6 | 82.62 |
| Change | - | -16.06% | 15.76% | 11.3% | -38.03% | -40.39% |
| P/E | 31x | 23.6x | 24.3x | 28.8x | 19.2x | 12.3x |
| PBR | - | 15.2x | - | 19.1x | 12.4x | 8.01x |
| PEG | - | 1.7x | 2.86x | -8.41x | -3.07x | -2.45x |
| Capitalization / Revenue | 18.9x | 15.3x | - | 16.9x | 11x | 7x |
| EV / Revenue | 18.9x | 14.8x | - | 16.4x | 10.6x | 6.61x |
| EV / EBITDA | - | 18x | - | 20.7x | 13.7x | 8.7x |
| EV / EBIT | - | 18.7x | - | 20.8x | 14x | 8.79x |
| EV / FCF | - | 23x | - | 26.9x | 19.8x | 11x |
| FCF Yield | - | 4.35% | - | 3.72% | 5.06% | 9.08% |
| Dividend per Share 2 | - | 1.26 | - | 1.55 | 1.5 | 1.5 |
| Rate of return | - | 3.65% | - | 3.52% | 5.45% | 8.96% |
| EPS 2 | 1.279 | 1.459 | 1.583 | 1.529 | 1.433 | 1.361 |
| Distribution rate | - | 86.4% | - | 101% | 105% | 110% |
| Net sales 1 | 10.93 | 11.72 | - | 13.61 | 13.12 | 12.5 |
| EBITDA 1 | - | 9.662 | - | 10.79 | 10.09 | 9.5 |
| EBIT 1 | - | 9.274 | - | 10.77 | 9.904 | 9.4 |
| Net income 1 | 6.731 | 7.674 | 8.372 | 8.097 | 7.584 | 7.1 |
| Net Debt 1 | - | -6.127 | - | -5.999 | -5.079 | -4.9 |
| Reference price 2 | 39.70 | 34.50 | 38.50 | 44.00 | 27.50 | 16.75 |
| Nbr of stocks (in thousands) | 5,209 | 5,209 | 5,220 | 5,220 | 5,225 | 5,225 |
| Announcement Date | 10/18/21 | 10/24/22 | 10/30/23 | 10/28/24 | 10/27/25 | - |
1GBP in Million2GBP
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 12.31x | 6.61x | 8.7x | 8.96% | 116M | |
| 21.73x | 7.71x | 15.48x | 1.37% | 74.16B | |
| 29.82x | 8.57x | 26.7x | 0.04% | 57.39B | |
| 32.98x | 5.93x | 17.77x | 0.98% | 47.64B | |
| -21.31x | 230.81x | -22.97x | -.--% | 44.29B | |
| 33.26x | 3.23x | 13.97x | -.--% | 42.5B | |
| 46.77x | 5.41x | 29.66x | -.--% | 40.71B | |
| 27.63x | 7.93x | 20.48x | 0.41% | 30.97B | |
| 32.99x | 7.05x | 18.3x | -.--% | 28.53B | |
| -15.1x | 5.68x | -7.14x | -.--% | 24.34B | |
| Average | 20.11x | 28.89x | 12.09x | 1.18% | 39.06B | |
| Weighted average by Cap. | 22.27x | 32.03x | 13.55x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BVXP Stock
- Valuation Bioventix PLC
Select your edition
All financial news and data tailored to specific country editions
